arrow
L

Lisa Domegan

health service executive
H指数:24
被引数:2,101

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

COVID-19 Vaccine Effectiveness Against Hospitalization in Older Adults, VEBIS Hospital Network, Europe, September 2024–May 2025

COVID-19疫苗在老年人群中的住院防护效果,欧洲VEBIS医院网络,2024年9月–2025年5月

2025-11-250
OAAI
Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study

关于接种后时间对疫苗效力估计与报告的建议:一项COVID-19病例研究

2025-11-170
OA
The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population
2025-08-012
OA
COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network

欧洲目标人群中针对需要医疗干预的SARS-CoV-2症状性感染的COVID-19疫苗有效性(2024年10月至2025年1月,VEBIS初级保健网络)

2025-05-210
OA
Human respiratory syncytial virus genetic diversity and lineage replacement in Ireland pre- and post-COVID-19 pandemic
2025-03-010
OAAI
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study
2024-09-018
PRE
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
2024-04-112
OAAI
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
2024-03-286
OAAI
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network

欧洲2022/2023流感A(H1N1)pdm09,A(H3N2) 和B循环混合季节期间成人流感住院的疫苗有效性: VEBIS SARI VE医院网络

2024-02-254
OA
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study

欧洲流感疫苗的有效性: 2022 2023 VEBIS (疫苗有效性,负担和影响研究) 初级保健多中心研究的结果

2024-01-107
OAAI
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021

疫苗对成人 (≥ 20岁) 在 α 和 δ 优势循环期间新型冠状病毒肺炎住院的有效性: I-MOVE-COVID-19和VEBIS SARI VE网络,欧洲,2021

2023-11-231
OAAI
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE- COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022

Omicron主导循环期间成人 (≥ 20岁) 新型冠状病毒肺炎住院的疫苗有效性: i-move新型冠状病毒肺炎和VEBIS SARI VE网络,欧洲,2022年2021

2023-11-236
OAAI